Overview
- 54 inspections across 50 sites are on record.
- 156 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-07-14.
At a glance
Inspections
54
Sites
50
Observations
156
Career since
Sep 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Sentara Enterprises dba Sentara Infusion Services (Blue Ridge) | 14 Jul 2023 | Human Drugs | View 483 → |
| Estee Lauder Cosmetics Ltd | 24 Feb 2023 | Human Drugs | View 483 → |
| ANI Pharmaceuticals Canada, Inc. | 17 Feb 2023 | Human Drugs | View 483 → |
| Pacific Rim Laboratories Inc | 10 Feb 2023 | Human Drugs | On file |
| AstraZeneca Pharmaceuticals LP | 19 Jan 2023 | Human Drugs | On file |
Sites inspected
Sentara Enterprises dba Sentara Infusion Services (Blue Ridge)Charlottesville, United States1 insp.
Estee Lauder Cosmetics LtdScarborough, Canada1 insp.
ANI Pharmaceuticals Canada, Inc.Oakville, Canada1 insp.
Pacific Rim Laboratories IncSurrey, Canada1 insp.
AstraZeneca Pharmaceuticals LPFrederick, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Tekalign Wondimu5 shared
Brandy N Lepage5 shared
Amy N Chen3 shared
Nicole E Knowlton3 shared
Austin B Appler3 shared
Tanya R Syffrard2 shared
Karen A Briggs2 shared
Jose A Lopez Rubet2 shared
Pratik S Upadhyay2 shared
Anastasia M Shields1 shared
Full investigator report
Get the verbatim findings behind Sena G Dissmeyer's 156 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site